胃癌手术治疗的进展。

IF 2.5 3区医学 Q2 HEMATOLOGY

Hematology-Oncology Clinics of North America Pub Date : 2024-02-23 DOI:10.1016/j.hoc.2024.01.003

Emily E. Stroobant MD , Vivian E. Strong MD

引用次数: 0

摘要

胃癌手术的目标是显微镜下阴性切除边缘和 D2 淋巴腺切除。微创技术（腹腔镜和机器人）已被证明与肿瘤治疗效果相当，但恢复更快。内镜粘膜切除术可用于T1a N0肿瘤切除术。由于对遗传性胃癌和分子亚型有了更深入的了解，因此针对 MSI 高肿瘤和 CDH1 基因突变患者提出了专门的建议。未来，外科治疗将支持微创方法和基于亚型的个性化癌症治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Advances in Gastric Cancer Surgical Management

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hematology-Oncology Clinics of North America 医学-血液学

CiteScore

4.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.